Literature DB >> 19067238

Collision metastasis of breast and ovarian adenocarcinoma in axillary lymph nodes: a case report and review of the literature.

Maher A Sughayer1, Lama Zakarneh, Raffat Abu-Shakra.   

Abstract

Despite their accepted clinical and genetic association, the incidence of synchronous breast and ovarian carcinoma is rare. Moreover, collision metastasis from both breast and ovarian carcinomas to the same lymph node, to our knowledge has never been reported. Review of the literature revealed eleven cases of metastatic malignant tumors colliding in the same lymph node, none of which had both ovarian and breast carcinoma. Our case was that of a 63 year old woman presenting with a breast lump that was diagnosed as infiltrating ductal carcinoma after a needle biopsy. One month later the patient was found to have malignant ascites, omental carcinomatosis and an ovarian mass. Histology and immunohistochemistry revealed high grade serous papillary adenocarcinoma. When surgery was done to treat the breast tumor some of the axillary lymph nodes revealed metastases from the breast primary, others metastases from the ovarian primary and one had both tumors in a collision phenomenon. Immunohistochemistry was used to confirm this finding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19067238     DOI: 10.1007/s12253-008-9141-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  12 in total

1.  Collision metastasis of prostatic and colonic adenocarcinoma: report of 2 cases.

Authors:  Zane K Wade; John E Shippey; Gregory A Hamon; Robert L Smoak; Pedram Argani; William C Allsbrook
Journal:  Arch Pathol Lab Med       Date:  2004-03       Impact factor: 5.534

2.  Lymph node metastases of prostatic adenocarcinoma in the mesorectum in patients with adenocarcinoma or villous tumor of the rectum with collision phenomenon in a single lymph node: report of five cases.

Authors:  Najat Mourra; Yann Parc; Deborah McNamara; Emmanuel Tiret; Jean-Francois Flejou; Rolland Parc
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

3.  Concurrent interfollicular Hodgkin's disease and metastatic breast carcinoma in lymph nodes.

Authors:  A S Allal; J Weintraub; S Remadi; R Abele
Journal:  Pathol Int       Date:  1996-10       Impact factor: 2.534

4.  Collision metastasis of bladder and prostate carcinoma to a single pelvic lymph node.

Authors:  A Ergen; M D Balbay; M Irwin; R Torno
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  "Collision phenomenon" of prostate and bladder cancers in lymph node metastases.

Authors:  K Gohji; M Nomi; T Kizaki; S Maruyama; K Morisue; A Fujii
Journal:  Int J Urol       Date:  1997-03       Impact factor: 3.369

6.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Authors:  R Wooster; S L Neuhausen; J Mangion; Y Quirk; D Ford; N Collins; K Nguyen; S Seal; T Tran; D Averill
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

Review 7.  Kaposi's sarcoma in lymph nodes concurrent with Hodgkin's disease.

Authors:  A Carbone; R Volpe
Journal:  Am J Clin Pathol       Date:  1983-08       Impact factor: 2.493

8.  Urothelial and prostate carcinoma metastasizing to the same lymph node: a case report and review of the literature.

Authors:  K Overstreet; P Haghighi
Journal:  Arch Pathol Lab Med       Date:  2001-10       Impact factor: 5.534

9.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  Concurrent medullary and papillary carcinomas of thyroid with lymph node metastases. A collision phenomenon.

Authors:  G C Pastolero; C I Coire; S L Asa
Journal:  Am J Surg Pathol       Date:  1996-02       Impact factor: 6.394

View more
  7 in total

1.  Collision metastases of breast and rectal carcinoma--a possible role for chemokines receptors expression.

Authors:  Maria Gabriela Gasparinho; Sónia Morgado; Ricardo Fonseca; Paula Chaves
Journal:  Pathol Oncol Res       Date:  2011-09-28       Impact factor: 3.201

2.  Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma.

Authors:  John R Jalas; Swapna Vemula; Vladimir Bezrookove; Philip E Leboit; Jeffry P Simko; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

3.  Collision metastasis of breast and thyroid carcinoma to a single cervical lymph node: report of a case.

Authors:  Hong Zeng; Chao Liu; Yun-jie Zeng; Lin Wang; Geng-biao Chen; Xi-ming Shen
Journal:  Surg Today       Date:  2012-04-07       Impact factor: 2.549

4.  Prostatic adenocarcinoma metastatic to pleomorphic liposarcoma, a "collision phenomenon": report of a case with review of pelvic collision tumors.

Authors:  Somak Roy; Ronald L Hrebinko; Kathleen M Cieply; Anil V Parwani; Uma N M Rao
Journal:  Patholog Res Int       Date:  2011-08-22

5.  Axillary metastasis from an occult tubal serous carcinoma in a patient with ipsilateral breast carcinoma: a potential diagnostic pitfall.

Authors:  Chantal Atallah; Gulbeyaz Altinel; Lili Fu; Jocelyne Arseneau; Atilla Omeroglu
Journal:  Case Rep Pathol       Date:  2014-07-09

6.  Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers.

Authors:  Jalal Raoufi; Serhan Can İşcan; Candost Hanedan; Emine Elif Özkan; Sevim Süreyya Çerçi; Ebru Erdemoğlu; Evrim Erdemoğlu
Journal:  Turk J Obstet Gynecol       Date:  2018-06-21

7.  Collision nodal metastasis of bladder cancer and melanoma: The first reported case and literature review.

Authors:  Francesca Sanguedolce; Francesco Troiano; Giovanni Musci; Magda Zanelii; Maurizio Zizzo; Stefano Ascani; Giuseppe Carrieri; Luigi Cormio
Journal:  Curr Urol       Date:  2022-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.